SM
DVAX

SG3 Management’s Dynavax Technologies DVAX Stock Holding History

SG3 Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,000
Closed -$288K – 1103
2021
Q3 		$288K Buy
+15,000
New +$199K 0.01% 711
2017
Q2 		– Sell
-6,000
Closed -$36K – 238
2017
Q1 		$36K Hold
6,000
– – 0.01% 208
2016
Q4 		$24K Buy
+6,000
New +$44K ﹤0.01% 239

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SG3 Management's DVAX Position: Q2 2021 in Review

SG3 Management sold out of Dynavax Technologies (DVAX) in Q2 2021, closing a stake of 20,000 shares — an estimated $197K sold.

SG3 Management first reported a position in DVAX in Q4 2016 and held it in 3 quarters. The position peaked at $197K in Q1 2021. 154 funds tracked by Wall St. Rank hold DVAX as of Q2 2021.

  • SG3 Management reported no remaining Dynavax Technologies position as of Q2 2021 after selling out during the quarter.
  • SG3 Management sold 20,000 Dynavax Technologies shares in Q2 2021, an estimated $197K.
  • SG3 Management first reported a position in Dynavax Technologies in Q4 2016 and held it in 3 quarters.
  • SG3 Management's Dynavax Technologies position peaked at $197K in Q1 2021.
  • 154 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2021.

Based on SG3 Management's 13F filing for Q2 2021, filed 16 Aug 2021.